Symrise and Probi sign joint research and development agreement

Probi (http://www.probi.com) has signed a research and development agreement
with the German company Symrise (http://www.symrise.com), a leading manufacturer
of flavours, fragrances, cosmetics and health ingredients. In response to a
growing consumer interest, the companies have decided to jointly develop
innovative probiotic products with documented health benefits. The cooperation
will initially focus on oral health.

Probi is a pioneer in research, development and manufacturing of probiotics.
Probi’s probiotics are included in some of the most effective products for gut
and immune health currently available on the global market. Expanding into new
areas such as oral health will offer additional growth potential for the
company.

Symrise has considerable expertise in research, development and manufacture of
foods, beverages, cosmetics and pharmaceutical products and sees major potential
in the health benefits of probiotics. The company also holds a globally leading
position in the area of oral care.

The companies will collaborate to identify and examine various probiotic strains
for use in oral health. Symrise has the capacity to screen and evaluate effects
of active substances, which has made it possible to build a portfolio of active
ingredients in cosmetics, nutrition and pharmaceuticals.

“The high level of expertise that Symrise possesses in sensory science, active
ingredients and applications, combined with Probi’s expertise in probiotics,
will provide us with the potential to jointly develop completely new and well
-flavoured consumer products with distinct health benefits,” says Michael
Oredsson, CEO of Probi AB.

“This partnership is a logical result of the growing demand for consumer
products with documented health benefits. Our complementary expertise and
strategic agendas in innovation will allow us to better support our customers in
their development and marketing,” says Dr. Heinz-Jürgen Bertram, President of
Symrise AG.

Symrise AG currently owns 14.97 % of the shares in Probi.

This is the type of information that Probi AB is required to disclose in
accordance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act.

FOR MORE INFORMATION, PLEASE CONTACT:
Michael Oredsson, CEO, Probi, tel. +46 46 286 89 23 or mobile +46 707 18 89 30,
e-mail: michael.oredsson@probi.se
Gun-Britt Fransson, Vice President R&D, Probi, tel. +46 46 286 89 23 or mobile
+46 705 95 73 27, e-mail: gun-britt.fransson@probi.se

ABOUT PROBI
Probi is a leading player in probiotic research and development of efficient and
well-documented probiotics. Its research areas include: gastrointestinal tracts,
immune system, metabolic syndrome and stress and recovery. Probi’s customer are
leading companies in the Functional Foods and Consumer HealthCare business
areas. Income for 2011 totalled MSEK 95.0. Probi’s share is listed on the Nasdaq
OMX Stockholm, Small Cap. Probi has approximately 5,000 shareholders. For more
information, please visit www.probi.se.

ABOUT SYMRISE
Symrise is a global supplier of fragrances, flavours, cosmetic active
ingredients and raw materials, as well as functional ingredients. Symrise
develops new product ideas and market-ready concepts of practical value to the
consumer by combining insight into consumer trends with cutting-edge technology
and innovative development. Customers include producers of perfumes, cosmetics,
food, pharmaceuticals and supplements. Sales for 2011 amounted to EUR 1.6
billion, placing Symrise among the four largest companies in the global aroma
market. Read more at www.symrise.com.